Unione Europea - croato - EMA (European Medicines Agency)

zoetis belgium sa - sarolaner - ektoparazitidi za sistemsku uporabu - psi - za liječenje gljivica, grinja (dermacentor reticulatus, krpelja ixodes hexagonus,rhipicephalus sanguineus i Иксодовых ricinusovog). veterinarski medicinski proizvod ima neposrednu i trajnu aktivnost ubijanja krpelja tijekom najmanje 5 tjedana. za liječenje infekcija buha (ctenocephalides felis i ctenocephalides canis). veterinarski medicinski proizvod ima neposrednu i trajnu aktivnost ubijanja buha protiv novih infestacija tijekom najmanje 5 tjedana. veterinarski lijek može se koristiti kao dio strategije liječenja za kontrolu flea allergy dermatitis (flea). za liječenje štitnjače (sarcoptes scabiei). za liječenje infekcija bradavica (otodectes cynotis). za liječenje demodikoze (demodex canis). blitve i krpelji moraju se priključiti na domaćina i početi hraniti kako bi bili izloženi aktivnoj tvari.

Unione Europea - croato - EMA (European Medicines Agency)

laboratorios hipra, s.a. - živjeti аттенуированного virus infektivne бурсальной bolesti (ibdv), procijediti 1052 - imunomodulatori za ptice, domaće peradi, živa virusna cjepiva, ptica zaraznih бурсальной bolesti virus (bolest Гамборо) - chicken; embryonated chicken eggs - za aktivne imunizacije 1-dnevne pilića i эмбрионами tovnih jaja za smanjenje kliničkih manifestacija i gubitka фабрициевой torbi, nošena vrlo вирулентные ptica zaraznih бурсальной bolesti virusne infekcije.

Unione Europea - croato - EMA (European Medicines Agency)

ceva santé animale - inactivated fimbrial adhesins of escherichia coli f4ab, inactivated fimbrial adhesins of escherichia coli f4ac, inactivated fimbrial adhesins of escherichia coli f5, inactivated fimbrial adhesins of escherichia coli f6 - imunološke za suidae - svinje - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6.

Unione Europea - croato - EMA (European Medicines Agency)

zoetis belgium - bedinvetmab - analgetici - psi - for the alleviation of pain associated with osteoarthritis in dogs.

Unione Europea - croato - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - piletina - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Unione Europea - croato - EMA (European Medicines Agency)

intervacc ab - recombinant streptococcus equi protein cce, recombinant streptococcus equi protein eq85, recombinant streptococcus equi protein idee - imunološke za kopitare - konji - for the active immunisation to reduce clinical signs and the number of abscesses in acute stage of infection with s. equi.

Unione Europea - croato - EMA (European Medicines Agency)

orion corporation - tasipimidine sulfate - other hypnotics and sedatives - psi - alleviation of situational anxiety and fear in dogs triggered by e. travel, noise, owner departure, veterinary visits.

Montenegro - croato - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

druŠtvo za proizvodnju, posredovanje i promet "urion" d.o.o. podgorica - bolnička, aparaturna oprema

Montenegro - croato - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"osmi red-d" d.o.o. podgorica - elektro-mehanička medicinska sredstva

Unione Europea - croato - EMA (European Medicines Agency)

les laboratoires servier - trifluridine, tipiracil hidroklorid - kolorektalne neoplazme - antineoplastična sredstva - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.